| Literature DB >> 21808644 |
Anupama Wadhwa1, Sunitha Kanchi Kandadai, Sujittra Tongpresert, Detlef Obal, Ralf Erich Gebhard.
Abstract
Nerve stimulation and ultrasound have been introduced to the practice of regional anesthesia mostly in the last two decades. Ultrasound did not gain as much popularity as the nerve stimulation until a decade ago because of the simplicity, accuracy and portability of the nerve stimulator. Ultrasound is now available in most academic centers practicing regional anesthesia and is a popular tool amongst trainees for performance of nerve blocks. This review article specifically discusses the role of ultrasonography for deeply situated nerves or plexuses such as the infraclavicular block for the upper extremity and lumbar plexus and sciatic nerve blocks for the lower extremity. Transitioning from nerve stimulation to ultrasound-guided blocks alone or in combination is beneficial in certain scenarios. However, not every patient undergoing regional anesthesia technique benefits from the use of ultrasound, especially when circumstances resulting in difficult visualization such as deep nerve blocks and/or block performed by inexperienced ultrasonographers. The use of ultrasound does not replace experience and knowledge of relevant anatomy, especially for visualization of deep structures. In certain scenarios, ultrasound may not offer additional value and substantial amount of time may be spent trying to find relevant structures or even provide a false sense of security, especially to an inexperienced operator. We look at available literature on the role of ultrasound for the performance of deep peripheral nerve blocks and its benefits.Entities:
Year: 2011 PMID: 21808644 PMCID: PMC3145343 DOI: 10.1155/2011/262070
Source DB: PubMed Journal: Anesthesiol Res Pract ISSN: 1687-6962
| Study | No. patients | Onset of block time (min) | Time for procedure completion (min) | Success rate (%) | Time to resolution of motor block (min) | Local anesthetic volume | Complications |
|---|---|---|---|---|---|---|---|
| Dingemans et al. [ | 72 | NA | 3.1 (US) versus 5.2 (USPNS) | 92% (US) versus 74% (USPNS) | NA | Lidocaine 1.5% and Bupivacaine.125% with epi 0.5 mL/kg | NA |
|
| |||||||
| Dhir and Ganapathy [ | 66 | 28 (NS) versus 24 (SC) versus 21(USPNS) | 6 (NS) versus | 59% (NS) versus 58% (SC) versus 96% (USPNS) | 266 (NS) versus 247 (SC) versus 246 (USPNS) | 30 mL of Ropivacaine 5 mg/mL with epi 2.5 | Secondary catheter failure 9% (US) versus 86% (USPNS) |
|
| |||||||
| Sauter et al. [ | 80 | 13.9 (US) versus 13.7 (USPNS) | 4.1 (US) versus | 95% (US) versus 85% (USPNS) | NA | 20 mL Lidocaine 0.5% & 20 mL Bupivacaine, 20 mL Levo-Bupivacaine 0.5% with epi 5 mg/mL | Vascular puncture 6.6% |
|
| |||||||
| Brull et al. [ | 103 | 5 (US) versus 10.5 (USPNS) | 5 (US) versus | 85% (US) versus 65% (USPNS) | NA | Lidocaine 2% 15 mL and 15 mL Bupivacaine 0.5% with epi | No difference in complications in the two groups |
|
| |||||||
| Taboada et al. [ | 70 | 17 (US) versus 19 (USPNS) | 3 (US) versus | 89% (US) versus 91% (USPNS) | 237 (US) versus 247 (USPNS) | NA | NA |
US: ultrasound, USPNS: ultrasound plus peripheral nerve stimulation, SC: stimulating catheter.